RecruitingNCT04681339

Antibiotic Prescription in Children Hospitalized for Community-acquired Pneumonia

Antibiotic Prescription in Children Hospitalized for Community-acquired Pneumonia: a Prospective, Observational Study


Sponsor

ARCIM Institute Academic Research in Complementary and Integrative Medicine

Enrollment

200 participants

Start Date

Sep 16, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

A study to observe how often antibiotics are prescribed in children hospitalized for pneumonia and how doctors decide if a child needs antibiotics or not. Parent satisfaction will also be recorded.


Eligibility

Min Age: 3 MonthsMax Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Antibiotic treatment and No antibiotic treatment for people with antibiotic stewardship and community acquired pneumonia in children. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 3 Months to 18 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERAntibiotic treatment

Antibiotic treatment

OTHERNo antibiotic treatment

No antibiotic treatment


Locations(2)

Die Filderklinik

Filderstadt, Baden-Wurttemberg, Germany

Herdecke Community Hospital

Herdecke, North Rhine-Westphalia, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04681339


Related Trials